Chromosomal band 1p34-36 is a commonly rearranged locus in many types of cancers. We cloned the breakpoint region of a chromosomal translocation, t(1;14)(p34;q32), found in the human multiple myeloma (MM) cell line, ODA. This rearrangement occurred between the nearby switch region of the immunoglobulin heavy chain (IgH) gene (Sc3) at 14q32 and the first intron of the human retinoic acid-inducible E3 protein (E3)/lysosomeassociated protein, transmembrane-5 (LAPTm5) gene at the 1p34 locus. Consequently, the E3 gene, which is a hematopoietic cell-specific transcript induced by retinoic acid and located at the rearranged allele, was interrupted within its coding region and was not expressed in the ODA cell line in spite of the other allele still being intact. The expression derived from the remaining intact allele in ODA cells was silenced by DNA methylation at sequences within the first intron around a GC-rich EagI site. Interestingly, the silenced expression of E3 mRNA due to DNA methylation of intron 1 sequences was frequently encountered in MM cells [6/10 (60%) of MM cell lines tested], while E3 is expressed in normal plasma cells and in most other hematopoietic cell lines including those of B-cell lineage. Thus, as the E3 protein has been suggested to be involved in cellular differentiation and apoptotic pathways in certain cell types, our results suggest that loss of E3 gene expression might be a crucial event during the progression of human MM.
Introduction
Structural alteration involving chromosome 1 band p34-36 represents a frequent cytogenetic aberration found in many types of human cancers, including hematological malignancies such as diffuse large B-cell lymphoma (DLCL), 1 marginal zone B-cell lymphoma (MZBCL) 2 and T-cell acute lymphoblastic leukemia (ALL). Deletions at this locus are often observed in breast cancer, neuroblastoma and leiomyosarcoma, [3] [4] [5] suggesting the existence of as yet unidentified tumor suppressor genes. On the other hand, recurrent chromosomal translocations, such as t(1;14)(p34;q32), t(1;7)(p34;q34), t(1;14)(p36;q11), suggest the involvement of novel proto-oncogenes deregulated as a result of these nonrandom rearrangements. As a matter of fact, LCK has already been identified as a target gene involved in t(1;7)(p34;q34), which is closely associated with T-cell ALL. 6 The cytogenetic profile of human multiple myeloma (MM) is characterized by complex chromosomal rearrangements representative of extreme chromosomal instability. While some of these chromosomal rearrangements may have occurred in a random fashion, other events may have occurred nonrandomly. Recurrent aberrations include those involving the immunoglobulin heavy (IgH) and light chain (Igk and Igl) gene loci. In particular, 14q+ chromosomes, which represent rearrangements between IgH and various donor chromosomal loci, such as 11q13, 6p25, 4p16, 16q23, 8q24 and 20q11, have been suggested to play crucial roles in MM development due to deregulation of Cyclin D1, 7 MUM1/IRF4, 8, 9 FGFR3, 10 c-MAF, c-MYC 12 and MAFB, 13 respectively. In order to characterize the novel chromosomal translocations involved in human MM and to find the relevant proto-oncogene(s)/tumor suppressor gene(s) involved, we isolated the 1p34 breakpoint region of t(1;14)(p34;q32) found in the human MM cell line, ODA.
Materials and methods

Cell lines
A total of 10 previously characterized MM cell lines (SK-MM-1, ODA, AMO1, NCU-MM-1, FR-4, NOP-1, KM5, SACHI, ILKM-2 and ILKM-3) were used in this study. 8, 9, [13] [14] [15] [16] [17] [18] The ODA cell line was originally established from a female patient with IgG-type MM, but had lost its ability to secrete the M protein as a result of long-term cell culture. G-banding analysis of the ODA cells revealed a complex karyotype featuring near-tetraploidy with two or three der (14) chromosomes.
Southern and Northern blot analysis
Southern and Northern blot analyses were performed as described previously. 8, 19 . The human IgH JH (6.6 kb BamHIHindIII) and IgH Cg3 (8.0 kb BamHI-HindIII) probes were kindly provided by Dr R Dalla-Favera (Columbia University, New York, NY, USA). For the Southern blot analysis, 10 mg of highmolecular-weight genomic DNA derived from ODA cells or normal human placenta was completely digested with either BamHI or HindIII, electrophoresed and blotted onto a nylon filter. The same filter was then sequentially hybridized with the IgJH and IgCg3 probes. Derivation of the chromosomal origin of the pB-ODA-1.1Sac fragment shown in Figure 4a was determined by Southern blot analysis using somatic cell hybrid DNA. GM/NA13139 human-mouse and GM/NA11535 human-Chinese hamster somatic cell hybrid DNA containing human chromosomes 1 and 14, respectively, were obtained through the NIGMS human mutant cell repository (Coriel Institute for Medical Research, Camden, NJ, USA). For Northern blot analysis, 10 mg of total RNA, isolated via a guanidine isothiocyanate/cesium chloride ultracentrifugation method, was loaded onto each lane. A 6.4 kb NotI/SalI fragment of KIAA0468 (syndecan-3 transcript) cDNA, which was kindly provided by Kazusa DNA Research Institute (Chiba, Japan), and the pSGL-3B-6.0NH genomic fragment indicated in Figure 4a or 2.2 kb of KIAA0085 (human retinoic acid-inducible E3 transcript) cDNA, which was also provided by Kazusa DNA Research Institute, were used as probes. The quality and quantity of each RNA preparation was assessed by subsequent hybridization with a b-ACTIN probe.
Molecular cloning of translocation breakpoint and DNA sequencing
High-molecular-weight DNA derived from ODA cells were completely digested with BamHI and size-fractionated with the aid of a low melting point agarose gel. DNA fragments ranging from 9 to 23 kb were gel-purified, ligated into the ldash II vector (Stratagene, La Jolla, CA, USA) and packaged in vitro. Duplicate sets of nitrocellulose filters containing 4 Â 10 5 recombinant phage plaques were screened by hybridization with either IgJH or IgCg3 probes. Isolated whole phage inserts were digested with BamHI and subcloned into pBluescript vectors for further analysis. Genomic walking at the 1p34 locus was performed by screening a genomic library constructed from human placenta using partially Sau3AI-digested DNA. DNA sequence analysis was performed with an ABI373A DNA sequencer (Applied Biosystems, Foster City, CA, USA). Sequence homology searches were performed using the BLAST server at the DNA Data Bank of Japan (DDBJ).
Construction of 1p34 BAC/PAC contig
The initial bacterial artificial chromosome (BAC) clone, 46o06, containing the 1p34 translocation breakpoint was isolated from a human BAC library purchased from Genome Systems (St Louis, MO, USA) by means of hybridization screening using the pB-ODA-1.1 Sac probe shown in Figure 4a . Both end fragments of the 46o06 insert were amplified via the modified bubble-PCR method and sequenced.
19 P1 artificial chromosome (PAC) clones containing identical sequences to the ends of BAC 46o06 were searched and obtained through the Sanger Centre Human Genome database (http://www.sanger.ac.uk/HGP/ Chr1). The 1p34 BAC/PAC contig was then constructed according to the sequence overlap and was reconfirmed on the basis of hybridization results with BAC/PAC end probes.
Double color FISH (DCFISH) analysis
The preparation of chromosomes used in the DCFISH analyses has been described previously. 9, 13, 20 Each PAC/BAC DNA was labeled with either Spectrum Orange or Spectrum Green with the aid of a nick translation kit (Vysis Inc., purchased through Fujisawa Pharmaceutical Co., Osaka, Japan) according to the manufacturer's instructions. DNA derived from YAC clone, Y6, spanning variable region (IgVH), and those of a bacteriophage clone, Igg1-10, or BAC417p24 (BAC/PAC Resources, Oakland, CA, USA) spanning the constant region were used as probes for the IgH gene at the 14q32 locus as previously described. 13, 20 Hybridization and washing protocols were the same as those available from the company (Vysis) via the Internet. Slides were counterstained with 4 0 , 6-diamino-2-phenylindole dihydrochloride (DAPI).
Immunoblot analysis
Rabbit anti-human E3/LAPTm5 polyclonal sera was raised against a peptide corresponding to its carboxyl terminus, CSKTPEGGPAPPPYSEVSKTP, as described previously. 21 Cell pellets prepared from the various cell lines were resuspended in 1 Â Laemmli sample buffer and boiled for 5 min. Total cell lysate derived from 1 Â 10 6 cells was fractionated on a 12.5% SDS acrylamide gel and transferred onto a nitrocellulose membrane (Schleicher & Schuell, Dassel, Germany). The blocking reaction and incubation with anti-human E3/LAPTm5 antibody, followed by incubation with anti-rabbit IgG horseradish peroxidaselinked antibody (Santa Cruz Biotechnology, CA, USA), was performed as previously described. 8, 18 Reactive bands were detected using an ECL system (Amersham).
Methylation analysis of the first intronic sequences of the E3/LAPTm5 gene Genomic DNA derived from the MM cell lines was completely digested with both HindIII and a methylation-sensitive rarecutting restriction enzyme, EagI, electrophoresed on a 0.8% gel, and Southern blot analysis performed. The filter was hybridized with an EcoRI-SacI 1.2 kb genomic fragment spanning exon 1 of the E3 gene and its surrounding intronic sequences. To see the effect on E3 mRNA expression of exposure to a demethylating agent, ODA and FR-4 cells were plated at 1 Â 10 6 /ml in the absence or presence of 1 mM 5-aza-2' deoxycytidine, cultured for 96 h and harvested for the preparation of total RNA. Northern blot analysis was performed as described above.
Results
ODA cells harbor (1;14)(p34;q32) chromosomal translocations
G-banding analysis of ODA cell metaphase spreads revealed the presence of two identical der(14) chromosomes in one nucleus (Figure 1 ), thus demonstrating the presence of chromosomal rearrangement between the IgH locus and an unidentified locus. To confirm the partner chromosome of the 14q32 locus, DCFISH analysis metaphase was performed using DNA derived from the YAC clone, Y6 (IgVH), and the bacteriophage clone, Igg1-10, labeled with Spectrum Orange and Green, respectively. Although a normal metaphase harbors two fusion signals at 14q32 loci, one of the signals was observed to be split in metaphases prepared from ODA cells. Specifically, the Spectrum Orange-labeled IgVH signal moved to the chromosome 1 band p34 locus, indicating reciprocal rearrangement between 1p34 and 14q32 loci in ODA cells (Figure 2a ).
Molecular cloning of a der(14)t(1;14) breakpoint in a ODA cell
Southern blot analysis of BamHI-digested ODA cell-derived genomic DNA with the Cg3 probe showed three rearranged bands ( Figure 3a) . Two of these, the 15 and 12 kb bands, did not comigrate with those bands detected with the JH probe, suggestive of being illegitimately rearranged fragments, thus demonstrating the presence of der (14)t(1;14)(p34;q32). In an attempt to isolate these fragments, a genomic library was constructed from ODA cells. Duplicate filters containing phage plaques were screened with Cg3 and JH probes, respectively. A phage clone (lODA-8) containing a Cg3 + JH À 12 kb fragment was also isolated, it was however determined to be generated as a result of internal class switch recombination within the IgH Figure 1 A representative G-banded picture of the ODA cell line. G-banding analysis of the ODA cells revealed near-tetraploidy with the presence of two der(14) chromosomes in a metaphase spread as shown by the arrowheads. The composite karyotype was 85, XX, -X, -X, der(1)t(1;16)(p11;p11)x2, der(1)t(1;20)(p11;p13), -1, -4, del(6)(q21q27)x2, add(6)(q11), der(7)(p36;p15)x2, del(8)(q23), der(8)t(3;8;11)(q12; p11q24;q13)x2, -9, -10, dic(1;11)(p11;p15)x2, add(11)(p15), ins(12;11)(p11;q13q23)x2, der(13)t(12;13)(p13q13)x2, der (14) FISH analysis in the 1p34 study. (a) Metaphase DCFISH analysis of an ODA cell using Spectrum Orange-labeled Y6 (IgVH) and Spectrum Green-labeled Igg1-10 provided evidence for splitting the IgH gene locus between variable and constant regions. An arrow and an arrowhead, respectively, indicate the Spectrum Orange-labeled IgVH signal, which has moved to the chromosome 1 band p34 locus, and the Spectrum Green-labeled Igg1-10 signal, which has remained on the derivative 14 chromosome. B. Mapping of Spectrum Green-labeled lhPL-8 DNA at the 1p34 locus in a metaphase spread derived from a normal lymphocyte, as shown by the two arrows. C. Fusion signals between Spectrum Orange-labeled IgH BAC 417p24 and Spectrum Green-labeled 1p34 PAC 898F17 on the interphase nuclei of ODA cells. Various numbers of fusion signals were detected in each nucleus, indicating that the ODA cells are heterogeneous in terms of the number of the der(14)t(1;14) chromosomes.
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Y Hayami et al gene (data not shown). We isolated another clone (lODA-3) representing a 15 kb fragment, whose centromeric sequences belonged to the vicinity of the switch g3 region of the IgH gene, while its telomeric sequences were replaced with ones of unknown origin (Figure 4a ). Its derivation was determined to be chromosome 1 by means of hybridization to a human-rodent somatic cell hybrid panel with a pODA-1.1Sac probe (Figure 3b ). The same probe was then used to isolate corresponding germline sequences of chromosome 1 from a human placental genomic DNA library. A clone, lhPL-8, was isolated and confirmed to belong to the chromosome 1p34 locus by FISH analysis using metaphase spreads derived from normal lymphocytes (Figure 2b ). This indicated that the lODA-3 insert spans the chromosomal breakpoint of der (14)t (1;14). Following repeated genomic walking steps, two neighboring phage clones were isolated, lhSGL-3 and lhPL-3, which extended in a telomeric direction. The detailed sequences around the translocation junction revealed that the breakpoint at the IgH locus occurred just 5 0 to the switch g3 sequences and the sequences derived from the 1p34 locus possessed neither a heptatmer-like signal for Ig gene rearrangement nor any similar consensus sequences for Ig switch regions (Figure 4d ). To isolate a phage clone representing a der(1)t(1;14), the Southern blot analysis of ODA cells using 1.8NH probe, which derived from the 1p34 locus as shown in Figure 4a , was performed (data not shown). However, we failed to identify any rearranged bands in digestion with BamHI or several other restriction enzymes, suggesting a possibility that the adjacent sequences nearby the breakpoint at the 1p34 locus were deleted.
1p34 breaks occurred within the E3/LAPTm5 gene, a hematopoietic-specific transcript induced by retinoic acid
Repeat-free fragments derived from the three phage inserts of chromosome 1 origin, found through hybridization with human Cot-1 DNA fragments (GIBCO BRL), were used for Northern blot analysis of ODA cells, along with other hematopoietic cell lines, in order to search for the relevant transcript within this locus. The pSGL-3B-6.2NH probe shown in Figure 4a detected a 2.5 kb transcript in various hematopoietic cell lines (Figure 5a , upper panel). These transcripts were confirmed by DNA sequence analysis to be derived from the E3/lysosome-associated protein, transmembnme-5 (LAPTm5) gene, a hematopoietic-specific transcript induced by retinoic acid. The E3 gene was juxtaposed to the 5' sequences to the Sg3 locus in the opposite direction to that of transcription. The genomic structure of E3 gene, which consists of 8 exons (Figure 4a ), was obtained through the National Center for Biotechnology Information Database. DNA sequence analysis near the breakpoint region revealed that the 1p34 breakpoint was located at the first intron of the E3 gene (Figure 4a) . No alternative translation initiation site was found downstream from the breakpoint in the E3 transcript. As normal plasma cells purified from normal volunteers using CD138-bead selection were shown to express E3 mRNA by means of reverse transcription (RT)-polymerase chain reaction (PCR) analysis (Figure 5b) , we examined its expression status in ODA cells. However, no evidence of E3 mRNA expression was shown in ODA cells (Figure 5a , upper panel), although Southern blot analysis using the E3 cDNA probe detected neither genomic deletion nor rearrangement at another allele harboring the E3 gene. In addition, ODA cells cultured in the presence of various retinoic acids also lacked E3 mRNA expression (data not shown). Two rearranged bands of approximately 15 (arrow) and 12 kb (arrowhead), which were revealed following hybridization with the Cg3 probe, did not comigrate with those detected by the JH probe, suggesting that these bands represented illegitimately rearranged fragments, providing evidence for the presence of der(14)t(1;14)(p34;q32). In contrast, the dotted line indicates a 10.5 kb band, which comigrated following hybridization with the JH and Cg3 probes, suggesting that it was a physiologically rearranged fragment. (b) Derivation of a pB-ODA1.1Sac fragment from chromosome 1. Somatic cell hybrid DNA, containing either human chromosome 1 or 14, was digested with EcoRI and loaded, along with human placenta, mouse and Chinese hamster DNA. The specific 20 kb band seen in the case of the human placental DNA was also observed in a somatic cell hybrid sample containing human chromosome 1-derived DNA. 
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Search for the transcriptional units mapped around the 1p34 breakpoint
Transcripts within BAC 46o06 were then searched using an exon trapping approach with the aid of an Exon trapping system (GIBCO BRL, Tokyo, Japan); however, only a few exons of the E3/LAPTm5 gene were obtained. Similar searches using PACs 1166h10, 1125n11, 201o14 and 898f17, which were isolated by hybridization with each PAC-end probes obtained via a bubble-PCR method or by sequencing BAC 46o06 clone followed by identification of the neighboring clones and were shown to overlap one another ( Figure 4b ). As DCFISH analysis demonstrated that PAC 898f17, but not PAC 1166h 10, fused to BAC 417p24, which encompasses the IgH constant regions and Ea locus (Figure 2c) , additional PAC clones extending in the direction dictated by PAC 898f17 were obtained in order to identify the target gene(s) deregulated by t (1;14) . The following genes, Syndecan-3, KIAA0099, PRO0611, HSPC251, FABP3, HPRP8BP and PRC0899 have been mapped around the 1p34 breakpoint within a distance of 750 kb (Figure 4c ). However, there was no evidence of expression of these transcripts in ODA cells as determined by Northern blot analysis using either cDNA or EST probes purchased from the Kazusa DNA Research Institute or Incyte Genomics Inc. (Palo Alto, CA, USA) (data not shown). Although the VH signal moved to the chromosome 1 as shown in Figure 2a , we could not show the evidence that 1p34 PAC 1166h10 fused to VH on der(1) chromosome, either, probably due to the deletion around the 5' region to the breakpoint in E3/LAPTm5 gene at 1p34 locus (data not shown). Thus, we could not search genes located on der(1), whose expression is altered in this cell line.
E3/LAPTm5 gene expression is frequently silenced by DNA methylation at the first intronic sequences in myeloma cell lines
Since the E3 gene was not expressed in the ODA cell line, in spite of the other nonrearranged allele being intact, we explored the possibility that promoter methylation was responsible for silencing of E3 expression in these cells. For this purpose, Southern blot analysis was performed using DNA doubledigested with HindIII and EagI, which is the methylationsensitive restriction enzyme located within GC-rich sequences of intron 1, with E3ex1 being used as the probe (Figure 6b ). In this analysis, methylated or nonmethylated EagI sites generate, respectively, either a single 6.1 kb band or two bands of 4.9 and 1.2 kb. In MM lines with methylated EagI sites at intron 1, such as ODA, FR-4, KM-5, NOP-1 and SK-MM-1, E3 mRNA expression was not detectable by Northern blot analysis (Figure 6a ). In the various cell lines examined, expression of E3/LAPTm5 mRNA correlated well with that of the protein level (Figure 5a, lower panel) . To reconfirm that DNA methylation of the first intron within the E3 gene is associated with silenced expression of its mRNA, we treated ODA or FR-4 cells with 1 mM 5-aza-2 0 deoxycytidine for 96 h and analyzed E3 mRNA expression by Northern blot analysis (Figure 6c ). As expected, E3 expression was partially restored in both cell lines, indicating that silenced expression of the E3 gene was caused by DNA methylation of the promoter sequences probably around the EagI site (Figure 6c ). As E3/LAPTm5 was assumed to be a candidate for the tumor suppressor gene from the aforementioned point of view, we next examined whether the gene mutation exists in SACHI, AMO1, ILKM-2 and ILKM-3 cell lines, which expressed E3 mRNA. Although we performed full-length sequencing of the E3 coding region in these MM cell lines, no somatic mutations except for a couple of polymorphic replacements were found. We next tried to examine the expression status of E3/LAPTm5 mRNA by means of RT-PCR analysis using RNAs derived from marrow plasma cells obtained by CD138-bead selection from 10 patients with fresh plasma cell neoplasms including smoldering multiple myeloma (SMM), MM and plasma cell leukemia (PCL). However, all of the primary samples expressed E3/LAPTm5 mRNA in our experimental condition (Figure 5b and some data not shown).
Discussion
In this study, we cloned a 1p34 breakpoint of a nonrandom chromosomal translocation, (1;14)(p34;q32), which is associated with a small fraction of mature B-cell malignancies. To Marrow plasma cells derived from normal volunteers and myeloma patients were purified using CD138 bead selection with an aid of AutoMACS (Miltenyi Biotec, Paris, France). After incubation with DNaseI, 1 mg of the total RNA was reverse transcribed and dissolved in a total volume of 20 ml as a first-strand cDNA solution. A volume of 2 ml of this solution was used to amplify E3/LAPTm5 or bactin mRNAs. The oligonucleotide primers used for the amplification of E3/LAPTm5 were as follows: for E3/LAPTm5, sense:
0 . NPC, normal plasma cell; SMM, smoldering multiple myeloma; MM, multiple myeloma; PCL, plasma cell leukemia.
Inactivation of E3/LAPTm5 in myeloma Y Hayami et al our knowledge, this is the first report on the details of this particular chromosomal rearrangement. The breakpoint disrupted coding sequences within the E3/LAPTm5 gene, which was originally identified as being upregulated by retinoic acid in a murine promyelocytic leukemia cell line.
22 E3 mRNA expression is restricted to hemato-lymphoid organs, such as bone marrow and spleen, although a low level of E3 expression is present in the thymus as shown by Northern blot analysis. Among lineages derived from hematopoietic origins, E3 expression is detected in myeloid, erythroid and B-lymphoid cells, while nonhematopoietic tissues do not contain detectable levels of E3 mRNA. The E3 product is thought to be a transmembrane protein and localized at lysosomal membranes. 21 Since E3 is an immediate-early response gene induced by retinoic acid and upregulated during the differentiation of myeloid cells into mature granulocytes, the E3 protein is assumed to play some role in the differentiation of myeloid lineages. This suggested to us that the E3 protein might have a similar function during the later stages of B-cell differentiation, although its functional role in B-cells remains unknown. Another interesting finding is that a highly homologous gene product to E3, GCD-10, which is specifically expressed in microglias, has been recently reported to be upregulated early during neuronal apoptosis. 23 Thus, the E3 protein may have some sort of function during the process of apoptosis of specific cell types. In an effort to pursue the function of E3 in B-cell lineage, we have transfected an E3 cDNA expression construct triggered by the CMV promoter into the Baf3 cell line, which is an interleukin-3(IL-3)-dependent mouse pro-B cell line, and obtained several clones stably expressing E3/LAPTm5. However, the growth rate of these E3/ LAPTm5-overexpressing cells was observed to be the same as that of mock-transfected cells (data not shown). Induction of apoptosis in the absence of IL-3 also occurred similarly in both cell lines (data not shown). It indicates that in the context of this limited experimental system the E3 gene does not occupy an important role in the pro-B-cell stage, whereas its role in terminal stage B cells needs to be clarified by further experiments in order to know whether the disruption of the E3 gene plays a role in acquiring a growth advantage of neoplastic plasma cells. As a matter of fact, ODA cells lack evidence of E3 transcript expression. As another E3 gene locus at the nontranslocated allele appears to be intact, the mechanism leading to transcriptional silencing of E3 expression was due to the promoter methylation, in a similar vein to that seen with the p16 or p21 tumor suppressor genes in various hematopoietic malignancies including multiple myeloma. [24] [25] [26] As silenced expression of the E3 gene was observed in 60% of the myeloma cell lines, this seems to be a frequent event in fully transformed myeloma cells including established cell lines. However, the purified plasma cells derived from patients with fresh plasma cell malignancies were shown to express E3 mRNA by RT-PCR analysis. We need to further investigate its expression level by RT/RQ(quantification)-PCR analysis or to perform methylationspecific PCR analysis of the first intronic sequences of the E3 gene to figure out the clinical significance of its silenced expression. We also need to determine what are the critical sequences within the promoter region responsible for silencing E3/LAPTm5 gene expression as a result of methylation of specific cytosines.
On the other hand, nonrandom chromosomal translocations involving immunoglobulin gene (Ig) loci in late B-cell malignancies usually activate the transcription of specific protooncogenes as a result of juxtaposition to Iga enhancer loci. 7, 8, 10, 11, 19, 27 The target genes transcriptionally deregulated on the 14g+ chromosomes found in human myeloma cells have been reported to occasionally exist as far as 500 kb away from the particular chromosomal breakpoints concerned, as in the case of t(11;14)(q13;q32), t(14;16)(q32;q23), and t(14;20) (q32;q11), which deregulate Cyclin D1, c-MAF and MAFB genes, respectively. 7, 11, 13 We therefore pursued the existence of the specific proto-oncogene deregulated by regulatory elements of the IgH gene. However, we have so far failed to identify this target proto-oncogene, despite having examined a number of candidates located up to 750 kb downstream from the 1p34 breakpoint. Of course, there remains a possibility that the target proto-oncogene exists 4750 kb downstream from the breakpoint or exists on the der(1)t(1;14) chromosome. Interestingly, however, the rearrangements between 1p34-36 and various chromosomal loci other than 14q32, such as 1q21, 1q25 and 9q 13, observed in 12% of lymphoma cases, are usually unbalanced and maintain only der(1)t(1;X)(p34-36;X) chromo- Inactivation of E3/LAPTm5 in myeloma Y Hayami et al somes (X represents chromosomal loci other than 14q32) in the tumor cells. 28 As they mostly coexist with t(14;18)(q32;q21), this suggests that these type of 1p34-36 rearrangements are secondary events closely associated with the later stages of disease progression. For this reason, such rearrangements may contribute to tumorigenesis by deleting one allele of the tumor suppressor gene mapped telomeric to the 1p34-36 breakpoints. This hypothesis is supported by a previous report that the p16 gene locus has been rearranged directly with T-cell receptor gene locus by virtue of t(9;14)(p21-22;q11), resulting in inactivation of this tumor suppressor gene. 29 Our assumption seems reasonable since important tumor suppressor genes are thought to exist in the 1p34-36 region. Further elucidation of E3/ LAPTm5 with respect to functional roles in plasma cells needs to be performed, along with a comprehensive analysis of a large number of fresh clinical materials derived from myeloma patients.
